China Asia Program Lead – Early Phase, R&D, Shanghai

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use . I further attest that all information I submit in my employment application is true to the best of my knowledge. Job Description Objective / Purpose: • The China Asia Program Lead – Early Phase (e-CAPL) is a scientific and clinical leader within Development, accountable for leading the China Asia Clinical Development Team – Early Phase (e-CADT) advancing early-phase assets through FIH to early proof of concept (ePOC) and signal seeking studies of clinical stage assets. Guided by Takeda’s values and commitment to Patient-Trust-Reputation (PTR), this role ensures that early clinical development decisions are grounded in strong science, patient focus, and ethical standards. • In close partnership with Global Program Leads and cross-functional stakeholders, the e-CAPL shapes and executes China-specific early development strategies aligned with global objectives. The role contributes critical clinical, translational, and scientific insights to enterprise portfolio decision-making, enabling timely, high-quality go/no-go decisions and maximizing the probability of success for early pipeline assets. Accountabilities: Describe the primary duties and responsibilities of the job. Include only the essential functions of the job. Approximately 5 – 10 bulleted task statements should be identified. Strategic Planning and Execution • Lead the e-CADT with a values-based leadership approach, fostering a culture of scientific excellence, accountability, inclusion, and continuous learning. • Define and execute China/Asia early clinical development strategies from first-in-human through ePOC, ensuring alignment with global development plans and Takeda’s enterprise priorities. • Provide scientific and clinical leadership for the design, execution, and interpretation of early-phase and signal-seeking clinical trials, including Phase I and exploratory Phase II studies. Job Description • Champion patient-centric trial design and ethical decision-making, ensuring patient safety and data integrity are prioritized at all times. • Drive strong cross-functional collaboration across Clinical science, Clinical Operation, Clinical Pharmacology, Biomarkers, Statistics, Regulatory, and other partners to enable integrated development strategies. • Act as the China early development subject-matter expert in global governance forums, influencing development strategy and key portfolio decisions with local insights, clarity and credibility. • Proactively identify scientific, clinical, and operational risks, demonstrating courage and ownership in addressing challenges, driving solutions, and balancing speed, quality, and value creation in line with Takeda’s long-term vision. • Build trusted relationships with investigators, key opinion leaders, and external partners to support innovative early clinical research in China. • Communicate program strategy, progress, risks, and results clearly to senior leadership and global stakeholders. Fiscal Responsibility • Responsible for project operating budgets within the regional program activities; monitor and control expenditures; manages variance between budgeted and actual expenditures of time, dollars, and personnel while meeting overall Takeda financial objectives. Resource and Issue Management • Manages internal and external resources (people, information, technologies, time, and capital); allocates project resources appropriately, given regional, function and individual goals and objectives to align with business imperatives. • Proactively identifies project issues before they arise and develops contingency plans; communicates project-related issues to senior executive management and manages issues to resolution. • Consults with GPLs and Senior Management in R&D China and APAC region to deliver accurate and timely project status and deliverable information to enable the organization to focus on key priorities and enhance its ability to deliver work on-time and on-budget. Change Management • Proactively responds to the dynamics of a changing marketplace; directs adjustments in functional or cross-divisional plans in response to changes in strategic direction. • Contributes to the creation and maintenance of systems/databases for the purpose of tracking key performance indicators (KPIs), trending, learning, and improving decisions regarding program performance and continuance. Matrix Team Management • Provides matrix management, strategic and tactical leadership to eCADT members who are responsible for leading the key deliverables or cross-functional teams within individual projects. Education & Competencies (Technical and Behavioral): List the essential and desirable education and competency requirements to perform the primary responsibilities of the job. Any minimum requirements should be noted. CORE ELEMENTS RELATED TO THIS ROLE: This position will lead and manage a matrix team of people and resources to take the accountability and achieve high levels of performance and improve the overall performance of early phase China clinical program activities. Program activities include planning towards milestones, defining clear go/no go decision points, managing critical path activities, proactively identifying issues, resolving conflicts and communicating project-related issues to senior executive management. EDUCATION, BEHAVIOURAL COMPETENCIES AND SKILLS: Education • Bachelor’s degree in science or business-related field • Advanced degree (MD, PhD, or equivalent) in medicine, life sciences, or a related scientific discipline. Experience • Minimum of 12 years of experience in pharmaceutical or biotechnology research and development, with significant hands-on leadership in early clinical development. • Minimum 8 years’ experience with increasingly complex pharmaceutical projects in a multi-disciplinary, global / regional environment including strategy development and execution • Minimum of 5 years matrix team management in a global / regional matrix team environment • Proven track record leading assets from IND/first-in-human through early proof of concept, including signal-seeking and hypothesis-driven studies. • Strong experience working in complex, global, matrix environments, with accountability for cross-functional and cross-regional outcomes. • Demonstrated people-management experience, including building, developing, and inspiring high-performing early clinical development teams. • Demonstrated ability to clearly and concisely communicate with and prepare presentations for Senior Management and Executives • Broad business orientation is highly preferred • Managed multiple submissions and approvals • Experience in autoimmune and/or immunology therapeutic areas is strongly preferred. Knowledge and Skills: • Deep scientific expertise in early clinical development, including clinical pharmacology, translational science, biomarker strategy, and early efficacy assessment. • Expert knowledge in the overall pharmaceutical drug development process, from discovery through post-marketing • Strong understanding of immunology and autoimmune disease biology, with the ability to translate scientific insights into clear clinical development strategies. • Thorough knowledge of early-phase drug